Zhivko Zhelev Selected Research

Zhivko Zhelev Research Topics

Disease

29	Neoplasms (Cancer) 12/2023 - 03/2004
12	Leukemia 01/2022 - 03/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2015
4	Myocardial Infarction 11/2022 - 01/2015
4	Carcinogenesis 10/2017 - 12/2010
4	Blast Crisis (Blast Phase) 09/2004 - 11/2003
3	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 12/2021
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2004
3	Hypercholesterolemia 01/2022 - 10/2011
3	Colonic Neoplasms (Colon Cancer) 09/2020 - 01/2016
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2004 - 04/2004
2	Acute Coronary Syndrome 01/2019 - 01/2015
2	Atherosclerosis 10/2017 - 08/2002
1	Breast Neoplasms (Breast Cancer) 03/2023
1	Triple Negative Breast Neoplasms 03/2023
1	Adenocarcinoma 03/2023
1	Non-ST Elevated Myocardial Infarction 11/2022
1	Milk Hypersensitivity (Milk Allergy) 10/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	ST Elevation Myocardial Infarction 01/2019
1	Pain (Aches) 06/2018
1	Chest Pain (Chest Pains) 06/2018
1	Neutropenia 03/2018
1	Lymphopenia (Lymphocytopenia) 03/2018
1	Eosinophilia 03/2018
1	Inflammation (Inflammations) 10/2017
1	Heart Diseases (Heart Disease) 08/2017

Drug/Important Bio-Agent (IBA)

10	Superoxides (Superoxide)IBA 05/2023 - 11/2013
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2015
8	nitroxylIBA 10/2017 - 12/2010
6	Vitamin K 3 (Menadione)FDA Link 03/2023 - 01/2018
6	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 01/2022 - 12/2015
5	Adenosine Triphosphate (ATP)IBA 05/2023 - 03/2004
5	NAD (NADH)IBA 01/2022 - 01/2020
5	Free RadicalsIBA 01/2020 - 04/2013
5	Everolimus FDA Link 01/2018 - 12/2015
5	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2005 - 11/2003
4	Succinic Acid (Succinate)IBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2015
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 01/2018
4	TEMPOIBA 05/2019 - 11/2013
3	quinone (benzoquinone)IBA 12/2023 - 01/2020
3	tumor-associated NADH oxidaseIBA 12/2023 - 01/2022
3	TroponinIBA 11/2022 - 06/2018
3	Drug CombinationsIBA 01/2022 - 01/2020
3	EnzymesIBA 01/2022 - 11/2003
3	VitaminsIBA 04/2020 - 08/2002
2	CholesterolIBA 03/2023 - 10/2011
2	Docosahexaenoic AcidsIBA 03/2023 - 04/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 01/2022
2	lonafarnib (SCH 66336)IBA 01/2022 - 04/2016
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 01/2020
2	Cytochromes b5 (Cytochrome b5)IBA 01/2020 - 01/2020
2	MelatoninIBA 10/2017 - 01/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2011 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 12/2010 - 01/2005
2	Messenger RNA (mRNA)IBA 09/2004 - 07/2004
2	LipofectamineIBA 09/2004 - 07/2004
2	Protein Kinase CIBA 08/2004 - 11/2003
2	bcr-abl Fusion ProteinsIBA 04/2004 - 11/2003
1	Coenzymes (Enzyme Cofactors)IBA 12/2023
1	QuinonesIBA 05/2023
1	Superoxide DismutaseIBA 03/2023
1	FenbendazoleIBA 03/2023
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 03/2023
1	Phenobarbital (Luminal)FDA Link 03/2023
1	trans-crotonin (CTN)IBA 11/2022
1	malic acid (malate)IBA 02/2022
1	Citric Acid (Citrate)FDA LinkGeneric 02/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	LipidsIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	NADP (NADPH)IBA 01/2022
1	Mevalonic Acid (Mevalonate)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 12/2021
1	CamptothecinIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LigandsIBA 01/2020
1	Cytostatic AgentsIBA 01/2020
1	Dicumarol (Dicoumarol)FDA Link 01/2020
1	FertilizersIBA 03/2018
1	Vitamin K FDA Link 01/2018
1	CalciumIBA 01/2018
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	6-Aminonicotinamide (6 Aminonicotinamide)IBA 11/2016
1	palbociclibIBA 04/2016
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2016
1	HydrogelsIBA 01/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2016
1	ManganeseIBA 01/2016

Therapy/Procedure

10	Therapeutics 03/2023 - 11/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2013
4	Quantum Dots (Quantum Dot) 01/2022 - 04/2005
1	Oral Administration 01/2020
1	Precision Medicine 01/2018
1	Aftercare (After-Treatment) 04/2016